外科左心耳封堵术后早期停用长期抗凝的安全性与结局
本研究基于2016至2019年接受冠脉搭桥或瓣膜手术并同期行外科左心耳封堵(sLAAO)的医保房颤抗凝患者,采用倾向评分匹配比较术后90天以上未继续抗凝者与继续抗凝者。结果显示早期停用抗凝者栓塞风险略高但大出血风险显著更低,复合终点无差异,且与未行sLAAO而继续抗凝者相比复合终点更低。
要点
- sLAAO术后早期停用长期抗凝者5年栓塞风险略高但大出血风险显著更低。
- 停用抗凝者与继续抗凝者的死亡、栓塞或大出血复合终点无差异。
- 与未行sLAAO且继续抗凝者相比,停用抗凝者复合终点更低。
核心结论
- sLAAO术后停用长期抗凝者5年内死亡、栓塞或大出血复合风险未增加,许多患者可接受长期结局。
研究设计与样本
- 纳入2016至2019年接受冠脉搭桥或瓣膜手术的医保房颤抗凝患者,经倾向评分匹配比较术后90天以上未继续抗凝者与继续抗凝者。
主要发现
- 10407例sLAAO患者中2470例(14.0%)早期停用抗凝,5年栓塞风险高1%(6.3% vs 5.3%;亚分布HR 1.32 [1.05-1.59];P=.043)。
- 早期停用抗凝者大出血风险更低(13.7% vs 17.8%;亚分布HR 0.68 [0.57-0.82];P<.001)。
- 死亡、栓塞或大出血复合终点无差异(34.0% vs 34.0%;HR 0.97 [0.86-1.10];P=.64)。
- sLAAO停用抗凝者与未行sLAAO继续抗凝者栓塞风险无差异(6.5% vs 6.5%;HR 1.20 [0.93-1.47];P=.18),复合终点更低(34.5% vs 38.6%;HR 0.84 [0.74-0.95];P=.006)。
临床怎么用
- 对于sLAAO术后房颤患者,可个体化评估早期停用长期抗凝的获益与风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical left atrial appendage occlusion (sLAAO) is known to prevent strokes in patients with atrial fibrillation (AF). However, for AF patients on long-term anticoagulation (AC), little is known about the safety of AC discontinuation after sLAAO. METHODS: The study included Medicare patients with AF on AC undergoing coronary artery bypass grafting or valve surgery from 2016 to 2019. By propensity score matching, patients who did not continue AC more than 90 days after surgery were compared with patients continuing AC. RESULTS: Of 10,407 patients undergoing sLAAO, 2470 (14.0%) exhibited early AC discontinuation and had 5-year risk of embolic events that was 1% higher (6.3% vs 5.3%; subdistribution hazard ratio [HR], 1.32 [1.05-1.59]; P = .043). However, the risk of major bleeding was much lower in those patients (13.7% vs 17.8%; subdistribution HR, 0.68 [0.57-0.82]; P < .001) such that no difference was observed in the composite outcome of mortality, embolism, or major bleeding (34.0% vs 34.0%; HR, 0.97 [0.86-1.10]; P = .64). Moreover, risk of embolism in sLAAO patients discontinuing AC was no different from that in AF patients continuing AC after surgery who did not undergo sLAAO (6.5% vs 6.5%; HR, 1.20 [0.93-1.47]; P = .18), and the risk of mortality, embolism, or major bleeding was lower (34.5% vs 38.6%; HR, 0.84 [0.74-0.95]; P = .006). CONCLUSIONS: AF patients on long-term AC who underwent sLAAO and discontinued AC after surgery were not at increased composite risk with respect to mortality, embolism, or major bleeding during 5 years. Discontinuation of long-term AC after sLAAO may be associated with acceptable long-term outcomes in many patients.
引用
- Goel NJ, Zhao Y, Sperry AE, et al. Early Discontinuation of Long-Term Anticoagulation After Surgical Left Atrial Appendage Occlusion. Ann Thorac Surg. 2026. PMID: 42119753. doi:10.1016/j.athoracsur.2026.04.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。